Kamunting Street Capital Management’s Pfizer PFE Stock Holding History

Kamunting Street Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-180,000	Closed	-$5.97M	–	29
2023 Q3	$5.97M	Buy	+180,000	New	+$6.37M	4.52%	10
2018 Q2	–	Sell	-57,970	Closed	-$1.95M	–	27
2018 Q1	$1.95M	Buy	57,970 +15,810	+38%	+$544K	1.53%	15
2017 Q4	$1.45M	Hold	42,160	–	–	1.03%	20
2017 Q3	$1.43M	Hold	42,160	–	–	0.9%	19
2017 Q2	$1.34M	Buy	+42,160	New	+$1.33M	1.07%	14

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Kamunting Street Capital Management's PFE Position: Q4 2023 in Review

Kamunting Street Capital Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 180,000 shares — an estimated $5.97M sold.

Kamunting Street Capital Management first reported a position in PFE in Q2 2017 and held it in 5 quarters. The position peaked at $5.97M in Q3 2023. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Kamunting Street Capital Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Kamunting Street Capital Management sold 180,000 Pfizer shares in Q4 2023, an estimated $5.97M.
Kamunting Street Capital Management first reported a position in Pfizer in Q2 2017 and held it in 5 quarters.
Kamunting Street Capital Management's Pfizer position peaked at $5.97M in Q3 2023.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Kamunting Street Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.